How you'll make an impact:, Lead individual projects to design and validate cell modification strategies, primarily leveraging mRNA and siRNA, that could enable near or long term engineering of cell function without altering the genome - various cell types including iPSCs, primary cells, and immune cells, Lead individual projects to design and validate novel intracellular detection strategies, primarily leveraging Portal's ability to deliver a wide range of impermeable probes and molecules into cells to measure intracellular target engagement and PPI, Contribute to platform development and testing for new implementations of Portal technology across research and clinical scales, Work cross-functionally with the Boston team to optimize ideal delivery strategies, Coordinate and serve as point-of-contact for studies and applications with external collaborators & clients, Your experience & qualifications:, PhD in bioengineering, molecular biology, cell biology, biochemistry, or related field with 0-2 years experience; or MS in molecular biology or related field with 3-5 years experience, Expertise in RNA biology and modalities of transient cell modification, Familiarity with cell biology, including metabolic pathways, immunology, etc., Experience with primary cell culture, assay development, qPCR, multicolor flow cytometry, Clear and effective communicator with strong interpersonal, organizational, and record-keeping skills, Experience with microarray and/or RNAseq a plus, Knowledge of genome engineering, CRISPR a plus, Ability to travel locally and to Boston as needed, 10-15%, Please note: Portal's headquarters are located in Watertown, MA. Company Overview:, Portal Biotechnologies, headquartered in Watertown, MA, is a rapidly scaling cell-engineering platform company operating across three high-value business lines (biopharma R&D screening, next-generation cell therapy manufacturing, and AI training data generation), addressing markets totaling $100B+.